 Subjects with impaired glucose tolerance will be randomized 1:1 to metforminplacebo treatment in a double-blinded way. Following a treatment run-in period of 17 days, two experimental days one with acute exercise and one without acute exercise, separated by one week, will be performed in each subject. 